Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Francisco, CA
NPI
1811182454
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1100 Van Ness Ave
San Francisco, CA, 94109
Phone (415) 600-0110
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,668 services
Medicare patients, 2024
306
Average age 73
Drug cost, 2024
$2.1M
3,915 prescriptions
Company payments, 2024
$43.85
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kjersti M Kirkeby was code 99214 (office e&m - established), 522 times for 265 patients. In total Kjersti M Kirkeby billed 1,668 services in 17 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 522 | 265 | $108.43 | $57K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 438 | 236 | $14.42 | $6,318 |
| 95251 Test - Miscellaneous | Office | 221 | 97 | $29.55 | $6,530 |
| 83036 Blood Count | Office | 171 | 105 | $9.52 | $1,628 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 113 | 41 | $49.99 | $5,649 |
| 82962 Clinical Chemistry | Office | 43 | 31 | $3.21 | $138 |
| 99232 Hospital E&M - Subsequent | Facility | 31 | 13 | $70.28 | $2,179 |
| 99204 Office E&M - New | Office | 29 | 29 | $150.89 | $4,376 |
| 99215 Office E&M - Established | Office | 17 | 15 | $152.63 | $2,595 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $148.18 | $1,630 |
By year: 2022 $92K for 1,327 services; 2023 $88K for 1,235 services; 2024 $90K for 1,668 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 171 | 105 | $9.52 | $1,628 |
| 82962 Clinical Chemistry | 43 | 31 | $3.21 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug Kjersti M Kirkeby prescribed most often to Medicare patients was Ozempic (Semaglutide), with 461 prescriptions and refills. In total Kjersti M Kirkeby wrote 3,915 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 461 | 761 | 106 | $693K |
| Jardiance Empagliflozin | 255 | 620 | 67 | $350K |
| Metformin Hcl Er Metformin Hcl | 251 | 619 | 70 | $3,880 |
| Atorvastatin Calcium Generic | 237 | 598 | 65 | $2,781 |
| Mounjaro Tirzepatide | 177 | 211 | 36 | $219K |
| Levothyroxine Sodium Generic | 165 | 448 | 47 | $3,053 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 152 | 310 | 51 | $17K |
| Metformin Hcl Generic | 147 | 422 | 46 | $2,120 |
| Glipizide Generic | 106 | 263 | 33 | $1,578 |
| Tresiba Flextouch U-100 Insulin Degludec | 101 | 224 | 36 | $60K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 98 | 171 | 22 | $41K |
| Losartan Potassium Generic | 82 | 244 | 24 | $699 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 82 | 208 | 33 | $12K |
| Synthroid Levothyroxine Sodium | 74 | 190 | 23 | $6,668 |
| Glipizide Er Glipizide | 73 | 166 | 21 | $968 |
Brand drugs: 2,050 claims; generic drugs: 1,576 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kjersti M Kirkeby $43.85 ($43.85 in general payments such as food, travel and fees) from 2 companies. The largest payer was Tandem Diabetes Care, Inc. with $23.33.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.